Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phagolysosomal acidification is a vital step in the maturation of the phagolysosome, where the activity of V-ATPase proton pumps and other factors lower the internal pH to between 4.5 and 5.0. This acidic environment is necessary for activating hydrolytic enzymes and facilitating the destruction of ingested microbes. Successful acidification requires fusion of the late phagosome with the lysosome, acquisition, and functional activation of V-ATPases, which convert ATP energy into proton translocation. Disruption of acidification by pathogens promotes their intracellular survival, while defective acidification in humans is associated with increased vulnerability to infections and immune dysregulation.
For drugs targeting V-ATPase—Inhibition of proton pumping into the phagolysosomal lumen, thereby raising internal pH and impairing hydrolytic activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagolysosomal acidification.